Aerosolized vascular endothelial growth factor/stromal cell-derived factor-1α (VEGFNP/SDFNP) led to a lower pulmonary arterial pressure and prevented right ventricular hypertrophy after ...

FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing ...

−5 was calculated from the formula: PA m = pulmonary arterial mean pressure ... of an elevated left atrial pressure and from an abnormally high pulmonary vascular resistance.

Pulmonary artery pressure monitoring systems use sensors to collect data on pulmonary artery pressure in people with chronic heart failure to allow for ongoing remote monitoring. A pulmonary artery ...

Pulmonary hypertension is a type of high blood pressure that affects the pulmonary artery (the artery that goes from the heart to the lungs) and the right side of the heart. Pulmonary hypertension is ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

F-FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing ...

Negative-pressure pulmonary edema (NPPE) occurs when a large, negative intrathoracic pressure is generated against an obstructed upper airway, causing fluid to shift into the lung interstitium.

Background: Imbalance between cell proliferation and apoptosis underlies the development of pulmonary arterial hypertension (PAH). Current vasodilator treatment of PAH does not target the uncontrolled ...

Pulmonary hypertension includes a range of conditions that occur when high blood pressure affects the arteries in the lungs ...